These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 14515176)
1. Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A. Dormond O; Rüegg C Thromb Haemost; 2003 Oct; 90(4):577-85. PubMed ID: 14515176 [TBL] [Abstract][Full Text] [Related]
2. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. Rüegg C; Dormond O; Mariotti A Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target? Rüegg C; Dormond O; Foletti A Endothelium; 2002; 9(3):151-60. PubMed ID: 12380640 [TBL] [Abstract][Full Text] [Related]
4. NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Dormond O; Foletti A; Paroz C; Rüegg C Nat Med; 2001 Sep; 7(9):1041-7. PubMed ID: 11533708 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling. Dormond O; Bezzi M; Mariotti A; Ruegg C J Biol Chem; 2002 Nov; 277(48):45838-46. PubMed ID: 12237321 [TBL] [Abstract][Full Text] [Related]
6. Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Rüegg C; Mariotti A Cell Mol Life Sci; 2003 Jun; 60(6):1135-57. PubMed ID: 12861381 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198 [TBL] [Abstract][Full Text] [Related]
9. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Alghisi GC; Rüegg C Endothelium; 2006; 13(2):113-35. PubMed ID: 16728329 [TBL] [Abstract][Full Text] [Related]
10. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433 [TBL] [Abstract][Full Text] [Related]
11. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256 [TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibitors. A new class of antiangiogenic agents. Masferrer JL; Koki A; Seibert K Ann N Y Acad Sci; 1999; 889():84-6. PubMed ID: 10668485 [TBL] [Abstract][Full Text] [Related]
13. Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. Kim S; Harris M; Varner JA J Biol Chem; 2000 Oct; 275(43):33920-8. PubMed ID: 10944524 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase as a target in lung cancer. Brown JR; DuBois RN Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972 [TBL] [Abstract][Full Text] [Related]
15. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM Clin Cancer Res; 2004 Sep; 10(17):5930-9. PubMed ID: 15355926 [TBL] [Abstract][Full Text] [Related]
16. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823 [TBL] [Abstract][Full Text] [Related]
17. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. Zaric J; Rüegg C J Biol Chem; 2005 Jan; 280(2):1077-85. PubMed ID: 15525653 [TBL] [Abstract][Full Text] [Related]
18. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. Tsuji S; Tsujii M; Kawano S; Hori M J Exp Clin Cancer Res; 2001 Mar; 20(1):117-29. PubMed ID: 11370818 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]